Related Experiment Video

Updated: Aug 30, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

[Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)]

Misao Tsukada1, Kazuho Honda, Kosaku Nitta

  • 1Department of Medicine, Kidney Center, Tokyo, Japan.

Nihon Jinzo Gakkai Shi
|November 25, 2003
PubMed

Insights

Incidental mesangial immunoglobulin A (IgA) deposition occurs in 23.8% of minimal change nephrotic syndrome (MCNS) patients and correlates with higher serum IgA levels. This finding does not impact MCNS treatment outcomes.

Area of Science:

  • Nephrology
  • Immunopathology

Context:

  • Minimal change nephrotic syndrome (MCNS) is a primary cause of nephrotic syndrome in children and adults.
  • The role of immunoglobulin A (IgA) deposition in MCNS is not fully understood.
  • Incidental IgA deposition in the glomeruli is a recognized finding in some kidney diseases.

Purpose:

  • To investigate the frequency and clinicopathological features of incidental mesangial IgA deposition in patients with MCNS.
  • To determine the association between mesangial IgA deposition and serum IgA levels.
  • To evaluate the impact of mesangial IgA deposition on the response to steroid treatment and clinical outcomes in MCNS.

Summary:

  • Mesangial IgA deposition was identified in 23.8% of MCNS patients.
  • A significantly higher serum IgA concentration was observed in patients with IgA deposition compared to those without (341 mg/dl vs. 252 mg/dl).
  • Mesangial IgA deposition did not influence proteinuria, renal function, or clinical outcomes after steroid treatment.

Impact:

  • This study highlights the frequent occurrence of incidental mesangial IgA deposition in MCNS.
  • The findings suggest that elevated serum IgA levels are associated with this deposition.
  • Importantly, mesangial IgA deposition does not appear to alter the prognosis or treatment response in MCNS patients.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

Published on: October 13, 2023

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...